Literature DB >> 15502091

Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool.

Hannes M Müller1, Simone Millinger, Heidi Fiegl, Georg Goebel, Lennart Ivarsson, Andreas Widschwendter, Elisabeth Müller-Holzner, Christian Marth, Martin Widschwendter.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15502091     DOI： 10.1373/clinchem.2004.034090

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  14 in total

1.  DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.

Authors:  Ceyhun E Kirimli; Wei-Heng Shih; Wan Y Shih
Journal:  Analyst       Date:  2014-06-07       Impact factor: 4.616

Review 2.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

3.  Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Mami Cantor; Gregory J Kirkner; Donna Spiegelman; G Mike Makrigiorgos; Daniel J Weisenberger; Peter W Laird; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

4.  Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.

Authors:  Shuji Ogino; Mohan Brahmandam; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charles S Fuchs
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

5.  Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.

Authors:  Veerle Melotte; Joo Mi Yi; Marjolein H F M Lentjes; Kim M Smits; Leander Van Neste; Hanneke E C Niessen; Kim A D Wouters; Joost Louwagie; Kornel E Schuebel; James G Herman; Stephen B Baylin; Wim van Criekinge; Gerrit A Meijer; Nita Ahuja; Manon van Engeland
Journal:  Cancer Prev Res (Phila)       Date:  2014-12-23

Review 6.  DNA methylation based biomarkers in non-invasive cancer screening.

Authors:  N Shivapurkar; A F Gazdar
Journal:  Curr Mol Med       Date:  2010-03       Impact factor: 2.222

7.  DNA methylation in circulating tumour DNA as a biomarker for cancer.

Authors:  Ruth E Board; Lucy Knight; Alastair Greystoke; Fiona H Blackhall; Andrew Hughes; Caroline Dive; Malcolm Ranson
Journal:  Biomark Insights       Date:  2008-01-25

8.  HOX genes in ovarian cancer.

Authors:  Zoë L Kelly; Agnieszka Michael; Simon Butler-Manuel; Hardev S Pandha; Richard Gl Morgan
Journal:  J Ovarian Res       Date:  2011-09-09       Impact factor: 4.234

9.  DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.

Authors:  Qinghua Wu; Ragnhild A Lothe; Terje Ahlquist; Ilvars Silins; Claes G Tropé; Francesca Micci; Jahn M Nesland; Zhenhe Suo; Guro E Lind
Journal:  Mol Cancer       Date:  2007-07-10       Impact factor: 27.401

10.  Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.

Authors:  Maria Jung; Svenja Pützer; Heidrun Gevensleben; Sebastian Meller; Glen Kristiansen; Dimo Dietrich
Journal:  Clin Epigenetics       Date:  2016-03-01       Impact factor: 6.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.